Press release —
Novus Scientific Announces TIGR® Matrix Surgical Mesh Distribution Agreement for Malaysia with Alpha-Health (Asia) Pte Ltd.
Tac-Whei Ong, Vice President, Global Sales & Marketing of Novus Scientific said: “Novus Scientific is delighted to be working with Alpha-Health (Asia) within the Malaysian market, as their core customers of plastic surgeons will benefit from an innovative product like TIGR® Matrix.”
TIGR® Matrix is the World’s 1st Long-Term Resorbable Synthetic Mesh. U.S. FDA cleared TIGR® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists in January 2010. It received CE Mark approval in August 2011.
TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.
CONTACT:
Tac-Whei Ong: +66-817 33 9524- tacwhei.ong@novusscientific.com
Topics
- Health, Health Care, Pharmaceuticals
Categories
- tigr matrix
- novus scientific
- surgical mesh
- malaysia
About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable (100% absorbable) synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company’s roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world’s foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States.
TIGR® Matrix - The world’s 1st long-term resorbable, 100% absorbable synthetic mesh with unique patented dual-fiber construction, designed for gradually increasing mechanical compliance.
TIGR® is a registered trademark of Novus Scientific Pte. Ltd
